Michelle N. Vu

2.0k total citations
14 papers, 471 citations indexed

About

Michelle N. Vu is a scholar working on Infectious Diseases, Molecular Biology and Animal Science and Zoology. According to data from OpenAlex, Michelle N. Vu has authored 14 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 4 papers in Molecular Biology and 3 papers in Animal Science and Zoology. Recurrent topics in Michelle N. Vu's work include SARS-CoV-2 and COVID-19 Research (8 papers), Influenza Virus Research Studies (3 papers) and COVID-19 Clinical Research Studies (3 papers). Michelle N. Vu is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), Influenza Virus Research Studies (3 papers) and COVID-19 Clinical Research Studies (3 papers). Michelle N. Vu collaborates with scholars based in United States, France and Lebanon. Michelle N. Vu's co-authors include Vineet D. Menachery, Kumari G. Lokugamage, Xuping Xie, Pei‐Yong Shi, Antonio E. Muruato, Xianwen Zhang, Kenneth S. Plante, Craig Schindewolf, Jessica A. Plante and Andrew Routh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and The Journal of Immunology.

In The Last Decade

Michelle N. Vu

14 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle N. Vu United States	8	354	142	93	76	57	14	471
Shaofeng Deng China	10	360 1.0×	100 0.7×	100 1.1×	65 0.9×	25 0.4×	21	501
Francisco J. Gutierrez-Alvarez Spain	10	599 1.7×	185 1.3×	196 2.1×	112 1.5×	37 0.6×	12	730
Deleah Pettie United States	5	562 1.6×	134 0.9×	82 0.9×	78 1.0×	22 0.4×	5	654
Judith M. Phillips United States	9	253 0.7×	87 0.6×	96 1.0×	80 1.1×	35 0.6×	11	421
Lindsey R. Robinson‐McCarthy United States	6	398 1.1×	151 1.1×	63 0.7×	72 0.9×	13 0.2×	12	484
Ruthiran Kugathasan United Kingdom	5	447 1.3×	137 1.0×	75 0.8×	59 0.8×	11 0.2×	7	532
Ikenna G. Madu United States	9	354 1.0×	155 1.1×	142 1.5×	45 0.6×	15 0.3×	10	492
Keiya Uriu Japan	6	395 1.1×	102 0.7×	67 0.7×	135 1.8×	13 0.2×	11	495
Javier Cantón Spain	5	292 0.8×	113 0.8×	100 1.1×	89 1.2×	37 0.6×	5	395
Francesca T. Bovier United States	9	345 1.0×	168 1.2×	32 0.3×	70 0.9×	17 0.3×	11	510

Countries citing papers authored by Michelle N. Vu

Since Specialization

Citations

This map shows the geographic impact of Michelle N. Vu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle N. Vu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle N. Vu more than expected).

Fields of papers citing papers by Michelle N. Vu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle N. Vu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle N. Vu. The network helps show where Michelle N. Vu may publish in the future.

Co-authorship network of co-authors of Michelle N. Vu

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle N. Vu. A scholar is included among the top collaborators of Michelle N. Vu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle N. Vu. Michelle N. Vu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Vu, Michelle N., Yiyang Zhou, Kumari G. Lokugamage, et al.. (2025). The furin cleavage site is required for pathogenesis, but not transmission, of SARS-CoV-2. Journal of Virology. 99(7). e0046725–e0046725. 1 indexed citations

Belser, Jessica A., Joanna A. Pulit-Penaloza, Nicole Brock, et al.. (2025). Ocular infectivity and replication of a clade 2.3.4.4b A(H5N1) influenza virus associated with human conjunctivitis in a dairy farm worker in the USA: an in-vitro and ferret study. The Lancet Microbe. 6(7). 101070–101070. 1 indexed citations

Sage, Valerie Le, Michelle N. Vu, Krishna Patel, et al.. (2024). Ventilation does not affect close-range transmission of influenza virus in a ferret playpen setup. Proceedings of the National Academy of Sciences. 121(33). e2322660121–e2322660121. 1 indexed citations

Schindewolf, Craig, Kumari G. Lokugamage, Michelle N. Vu, et al.. (2023). SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3. Journal of Virology. 97(2). e0153222–e0153222. 23 indexed citations

Johnson, Bryan A., Yiyang Zhou, Kumari G. Lokugamage, et al.. (2022). Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis. PLoS Pathogens. 18(6). e1010627–e1010627. 86 indexed citations

Vu, Michelle N., Kumari G. Lokugamage, Jessica A. Plante, et al.. (2022). QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2 infection and pathogenesis. Proceedings of the National Academy of Sciences. 119(32). e2205690119–e2205690119. 16 indexed citations

Bouin, Alexis, et al.. (2022). Enterovirus-Cardiomyocyte Interactions: Impact of Terminally Deleted Genomic RNAs on Viral and Host Functions. Journal of Virology. 97(1). e0142622–e0142622. 5 indexed citations

Vu, Michelle N. & Vineet D. Menachery. (2021). Binding and entering: COVID finds a new home. PLoS Pathogens. 17(8). e1009857–e1009857. 6 indexed citations

Xie, Xuping, Kumari G. Lokugamage, Xianwen Zhang, et al.. (2021). Engineering SARS-CoV-2 using a reverse genetic system. Nature Protocols. 16(3). 1761–1784. 106 indexed citations

10.

Matchett, William E., Vineet Joag, J. Michael Stolley, et al.. (2021). Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity. The Journal of Immunology. 207(2). 376–379. 102 indexed citations

11.

Muruato, Antonio E., Michelle N. Vu, Bryan A. Johnson, et al.. (2021). Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge. PLoS Biology. 19(11). e3001284–e3001284. 44 indexed citations

12.

Firpo, Mason R., et al.. (2020). Novel Ionophores Active against La Crosse Virus Identified through Rapid Antiviral Screening. Antimicrobial Agents and Chemotherapy. 64(6). 24 indexed citations

13.

Bouin, Alexis, Fanny Renois, Yohan N’Guyen, et al.. (2019). Enterovirus Persistence in Cardiac Cells of Patients With Idiopathic Dilated Cardiomyopathy Is Linked to 5’ Terminal Genomic RNA-Deleted Viral Populations With Viral-Encoded Proteinase Activities. Circulation. 139(20). 2326–2338. 49 indexed citations

14.

Wu, Yuanyuan, Andrew Nguyen, Michelle N. Vu, et al.. (2014). Antiphospholipid Antibodies Promote Tissue Factor–Dependent Angiogenic Switch and Tumor Progression. American Journal Of Pathology. 184(12). 3359–3375. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact